News

The approval is based on a trial that revealed that the system’s treatment led to improvements in disability and pain.
Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...
Our premium News+ ad-free experience – only $10 more every 4 weeks!